Neutral Lipid Storage Disease with Myopathy, also known as neutral lipid storage myopathy, is related to chanarin-dorfman syndrome and myopathy, and has symptoms including ataxia, muscle weakness and muscular fasciculation. An important gene associated with Neutral Lipid Storage Disease with Myopathy is PNPLA2 (Patatin Like Phospholipase Domain Containing 2). The drugs Bezafibrate and Hypolipidemic Agents have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and liver, and related phenotypes are progressive proximal muscle weakness and shoulder girdle muscle weakness